Market Newsdesk

• Solid execution in 2025: 2025 was a year of disciplined execution, with revenue growing 10.1% year over year to $430.9 million and Adjusted EBITDA margin reaching 21.3%. We accelerated top-line growth compared to 2024 while maintaining strong profitability and cash generation. These results reflect the structural strength of our marketplace model and our continued financial discipline.
• Continued expansion into complex, high-value projects: Our marketplace continued to evolve toward high-value work. Spend per buyer increased 13.3% year over year, accelerating from the prior year, while GMV from transactions over $1,000 grew 22.8%. The number of buyers spending over $10,000 annually also accelerated 7%. These trends validate our upmarket strategy and demonstrate the growing adoption of Dynamic Matching and Managed Services, enabling us to capture larger, more complex projects.
• Transformation plan underway: Since our restructuring in September, we have initiated a focused transformation to scale trust, quality, and AI-native capabilities across the platform. Anchored around upgrades in matching infrastructure, product experience, go-to-market execution, and operational excellence, this multi-year plan is designed to extend our leadership in high-value work while maintaining a disciplined cost structure. We expect to see measurable progress within the next four to six quarters.
• Resetting expectations to invest for long-term growth: As we execute this transformation, we are aligning expectations around a disciplined investment phase. While near-term growth may be volatile due to market conditions and the scope of our initiatives, we are committed to protecting structural profitability and generating healthy cash flow. We believe these investments position Fiverr to accelerate growth and drive value creation in 2027 and beyond.

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) — Fiverr International Ltd. (NYSE: FVRR), the company that is transforming the way the world creates and works together, today reported financial results for the fourth quarter and full year 2025. Additional operating results and management commentary can be found in the Company’s shareholder letter, which is posted to its investor relations website at investors.fiverr.com.

“As we close 2025, a year of disciplined execution for us, it is clear that we are living through a significant shift in AI adoption. We are seeing a profound migration on our marketplace where humans are becoming more essential, not less. By moving toward an agentic economy, where AI helps navigate complexity, we are ensuring that we remain the bridge between businesses and the most exceptional human talent. With our expansive global talent network, outcome based hiring model, and depth of proprietary data, Fiverr has a unique right to win in this new age of AI,” said Micha Kaufman, founder and CEO of Fiverr. “We have a multi-year plan to lead this transition, and I have never been more excited about the road ahead.”

“We finished the year with a record Adjusted EBITDA margin, a testament to the health of our business as we pivot upmarket. To accelerate our next phase of execution, we are aligning our leadership structure to better support this scalability. I am thrilled to see Esti step into the role of CFO, her knowledge and disciplined financial leadership provide the exact continuity we need to navigate this transformation. As President, my focus will remain on our long-term strategic investments and M&A efforts,” said Ofer Katz, President and CFO of Fiverr. “Looking towards 2026, we are prioritizing product innovation and platform re-architecture investments, while also maintaining a disciplined capital allocation strategy that ensures we have the flexibility to act on opportunities that align with our AI-native future.”

Fourth Quarter 2025 Financial Highlights

• Revenue in the fourth quarter of 2025 was $107.2 million, compared to $103.7 million in the fourth quarter of 2024, an increase of 3.4% year over year.
• Marketplace revenue in the fourth quarter of 2025 was $71.5 million, compared to $73.5 million in the fourth quarter of 2024, a decline of 2.7% year over year.
• Annual active buyers1 as of December 31, 2025, were 3.1 million, compared to 3.6 million as of December 31, 2024, a decline of 13.6% year over year.
• Annual spend per buyer1 as of December 31, 2025, reached $342, compared to $302 as of December 31, 2024, an increase of 13.3% year over year.
• Marketplace take rate1 for the twelve months period ended December 31, 2025, was 27.7%, an increase of 10 basis points from 27.6% for the twelve months period ended December 31, 2024.
• Services revenue in the fourth quarter of 2025 was $35.6 million, compared to $30.2 million in the fourth quarter of 2024, an increase of 18.2% year over year.
• GAAP gross margin in the fourth quarter of 2025 was 82.4%, an increase of 190 basis points from 80.5% in the fourth quarter of 2024. Non-GAAP gross margin1 in the fourth quarter of 2025 was 84.7%, an increase of 70 basis points from 84.0% in the fourth quarter of 2024.
• GAAP net income in the fourth quarter of 2025 was $11.5 million, or $0.32 basic net income per share and $0.31 diluted net income per share, compared to $12.8 million GAAP net income, or $0.36 basic net income per share and $0.33 diluted net income per share in the fourth quarter of 2024.
• Non-GAAP net income1 in the fourth quarter of 2025 was $32.1 million, or $0.89 basic non-GAAP net income per share1 and $0.86 diluted non-GAAP net income per share1, compared to $24.9 million non-GAAP net income1, or $0.70 basic non-GAAP net income per share1 and $0.64 diluted non-GAAP net income per share1, in the fourth quarter of 2024.
• Net cash provided by operating activities in the fourth quarter of 2025 was $21.9 million, compared to $30.0 million in the fourth quarter of 2024, a decrease of 27.2% year over year. Excluding one-time escrow payment for contingent consideration of $5.7 million in the fourth quarter of 2025, net cash provided by operating activities decreased by 8.1% year over year.
• Free cash flow1 in the fourth quarter of 2025 was $21.8 million, compared to $29.6 million in the fourth quarter of 2024, a decrease of 26.5% year over year. Excluding one-time escrow payment for contingent consideration of $5.7 million in the fourth quarter of 2025, free cash flow decreased by 7.1% year over year.
• Adjusted EBITDA1 in the fourth quarter of 2025 was $26.5 million, compared to $20.7 million in the fourth quarter of 2024. Adjusted EBITDA margin1 was 24.7% in the fourth quarter of 2025, compared to 20.0% in the fourth quarter of 2024, representing a 470 basis points improvement year over year.

Full Year 2025 Financial Highlights

• Revenue in 2025 was $430.9 million, compared to $391.5 million in 2024, an increase of 10.1% year over year.
• Marketplace revenue in 2025 was $297.5 million, compared to $303.1 million in 2024, a decline of 1.8% year over year.
• Services revenue in 2025 was $133.4 million, compared to $88.4 million in 2024, an increase of 50.9% year over year.
• GAAP gross margin in 2025 was 81.6%, a decrease of 40 basis points from 82.0% in 2024. Non-GAAP gross margin1 in 2025 was 84.4%, an increase of 10 basis points from 84.3% in 2024.
• GAAP net income in 2025 was $21.0 million, or $0.58 basic net income per share and $0.56 diluted net income per share, compared to a net income of $18.2 million, or $0.49 basic net income per share and $0.48 diluted net income per share in 2024.
• Non-GAAP net income1 in 2025 was $115.1 million, or $3.17 basic Non-GAAP net income per share1 and $2.95 diluted Non-GAAP net income per share1, compared to $95.1 million, or $2.57 basic Non-GAAP net income per share1 and $2.38 diluted Non-GAAP net income per share1, in 2024.
• Net cash provided by operating activities in 2025 was $104.6 million, compared to $83.1 million in 2024, an increase of 25.9% year over year. Net cash provided by operating activities, excluding one-time escrow payment for contingent consideration of $5.7 million in 2025 and $12.2 million in 2024, was $110.3 million in 2025, compared to $95.2 million in 2024, an increase of 15.9% year over year.
• Free cash flow1 in 2025 was $103.3 million, compared to $81.7 million in 2024, an increase of 26.5% year over year. Free cash flow1, excluding one-time escrow payment for contingent consideration of $5.7 million in 2025 and $12.2 million in 2024, was $109.0 million in 2025 compared to $93.8 million in 2024, an increase of 16.2% year over year.
• Adjusted EBITDA1 in 2025 was $91.6 million, compared to $74.2 million in 2024. Adjusted EBITDA margin1 was 21.3% in 2025, an increase of 230 basis points from 19.0% in 2024.

Financial Outlook

For Q1’26 and full-year 2026 guidance, the wider-than-normal revenue range reflects the elevated uncertainty on our business as the transformation plan underway focuses on high-value work, and intentionally deprioritizes incremental optimization of low-end transactions. This is coupled with the continued uncertainty around external market conditions. On Adjusted EBITDA, the updated guidance for this year reflects the revenue trends we see, as well as the impact from investments we’re making in foundational work. The core business unit economics remain structurally sound, and our ability to drive intrinsic leverage in the marketplace business model remains intact.

	Q1 2026	FY 2026
Revenue	$100 – $108 million	$380 – $420 million
y/y growth	(7)% – 1%	(12)% – (3)%
Adjusted EBITDA (1)	$19 – $23 million	$60 – $80 million

Leadership Transition

To support long-term growth and operational complexity, we are refining our executive leadership structure:

• President: Ofer Katz will continue to serve as President. By transitioning the CFO title, Ofer will now dedicate his time to driving strategic investments and leading M&A efforts.
• Chief Financial Officer: Esti Levy Dadon is being promoted to CFO, alongside overseeing multiple business and operational responsibilities. Esti has been with Fiverr for nearly a decade, serving as EVP Finance for the past four years.
• Chief Business Officer: Jinjin Qian is being promoted to the newly created CBO role, where she will oversee revenue, talent, fulfillment, and business operations. Jinjin has been leading IR and Strategy for the last seven years.

Conference Call and Webcast Details

Fiverr’s management will host a conference call to discuss its financial results on Wednesday, February 18, 2026, at 8:30 a.m. Eastern Time. A live webcast of the call can be accessed from Fiverr’s Investor Relations website. An archived version will be available on the website after the call. To participate in the conference call, please dial: Toll-Free: 1-833-630-1956 or International: 1-412-317-1837.

About Fiverr

Fiverr’s mission is to transform the way the world creates and works together. We’re shaping the future of work with the world’s leading open platform, seamlessly connecting top talent and cutting-edge technology with businesses around the globe. From expert freelancers in over 750 skilled categories to best-in-class GenAI models and agents, Fiverr provides the most advanced and comprehensive talent and tools for digital services—helping businesses get mission-critical projects done fast and cost-effectively.

From small businesses to Fortune 500 companies, millions trust Fiverr for projects in software and AI development, digital marketing, finance, business consulting, video animation, music, architecture, and more.

Learn how to future-proof your business with exceptional talent and cutting-edge tools at fiverr.com. Follow us on LinkedIn, Instagram, TikTok, and Facebook.

Investor Relations:
Jinjin Qian
Emily Greenstein
[email protected]

Press:
Jenny Chang
Tommy Lee
[email protected]

Source: Fiverr International Ltd.

CONSOLIDATED BALANCE SHEETS
(in thousands)
		December 31,				December 31,
			2025				2024
		(Unaudited)				(Audited)
Assets
Current assets:
Cash and cash equivalents		$	125,215			$	133,472
Marketable securities			117,705				288,947
User funds			159,849				153,309
Bank deposits			40,000				144,843
Restricted deposit			3,409				1,315
Other receivables			32,970				34,198
Total current assets			479,148				756,084
Long-term assets:
Marketable securities			–				122,009
Property and equipment, net			3,360				4,271
Operating lease right of use asset			3,513				5,122
Deferred Tax Assets, net			26,423				22,517
Intangible assets, net			36,554				41,882
Goodwill			126,313				110,218
Other non-current assets			7,795				7,871
Total long-term assets			203,958				313,890
TOTAL ASSETS		$	683,106			$	1,069,974
Liabilities and Shareholders’ Equity
Current liabilities:
Trade payables		$	9,081			$	5,533
User accounts			149,454				141,691
Deferred revenue			18,567				20,090
Other account payables and accrued expenses			66,931				57,167
Operating lease liabilities			3,365				2,608
Convertible notes, net			–				457,860
Total current liabilities			247,398				684,949
Long-term liabilities:
Operating lease liabilities			798				2,747
Other non-current liabilities			22,926				19,628
Total long-term liabilities			23,724				22,375
TOTAL LIABILITIES		$	271,122			$	707,324
Shareholders’ equity:
Share capital and additional paid-in capital			786,195				727,176
Accumulated deficit			(377,739	)			(366,193	)
Accumulated other comprehensive income			3,528				1,667
Total shareholders’ equity			411,984				362,650
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY		$	683,106			$	1,069,974

CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and pfb share data)
		Three Months Ended								Year Ended
		December 31,								December 31,
			2025				2024				2025				2024
		(Uaudited)								(Unaudited)				(Audited)
Revenue		$	107,174			$	103,666			$	430,909			$	391,481
Cost of revenue			18,870				20,201				79,416				70,566
Gross profit			88,304				83,465				351,493				320,915
Operating expenses:
Research and development			17,893				22,329				90,664				90,241
Sales and marketing			43,772				45,232				176,675				171,678
General and administrative			20,736				21,782				85,331				74,814
Total operating expenses			82,401				89,343				352,670				336,733
Operating income (loss)			5,903				(5,878	)			(1,177	)			(15,818	)
Financial income and other, net			3,899				5,662				24,593				27,706
Income (loss) before taxes on income			9,802				(216	)			23,416				11,888
Tax benefit (taxes on income)			1,658				13,054				(2,433	)			6,358
Net income attributable to ordinary shareholders		$	11,460			$	12,838			$	20,983			$	18,246
Basic net income per share attributable to ordinary shareholders		$	0.32			$	0.36			$	0.58			$	0.49
Basic weighted average ordinary shares			36,107,120				35,658,287				36,281,883				36,984,757
Diluted net income per share attributable to ordinary shareholders		$	0.31			$	0.33			$	0.56			$	0.48
Diluted weighted average ordinary shares			36,669,122				38,947,644				37,174,763				37,840,154

CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
		Three Months Ended								Year Ended
		December 31,								December 31,
			2025				2024				2025				2024
		(Uaudited)								(Unaudited)				(Audited)
Cash flows from operating activities:
Net income		$	11,460			$	12,838			$	20,983			$	18,246
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			3,245				4,328				14,692				10,476
Amortization of premium and accretion of discount of marketable securities, net			(309	)			(1,647	)			(1,134	)			(4,753	)
Amortization of discount and issuance costs of convertible notes			214				640				2,140				2,555
Shared-based compensation			9,655				18,020				51,389				73,942
Exchange rate fluctuations and other items, net			122				166				(391	)			226
Gain from sale of subsidiary			(750	)			–				(750	)			–
Impairment of intangible assets			–				–				2,400				–
Revaluation of earn outs			5,955				3,059				15,558				3,202
Changes in assets and liabilities:
User funds			8,442				6,017				(6,540	)			(1,707	)
Operating lease ROU assets and liabilities			52				89				417				(104	)
Other receivables			4,190				10,267				7,262				4,201
Deferred tax assets, net			1,000				(22,517	)			(3,785	)			(22,517	)
Trade payables			3,231				2,653				2,589				(409	)
Deferred revenue			(1,057	)			484				(1,523	)			2,275
User accounts			(6,250	)			(6,597	)			7,763				(512	)
Payment of earn out			–				(843	)			(2,714	)			(843	)
Escrow payment for contingent consideration			(5,746	)			–				(5,746	)			(12,168	)
Other accounts payable and accrued expenses			(12,691	)			1,098				983				7,967
Non-current liabilities			1,107				1,979				996				2,991
Net cash provided by operating activities			21,870				30,034				104,589				83,068
Investing Activities:
Investment in marketable securities			–				(56,606	)			(55,652	)			(87,340	)
Proceeds from maturities of marketable securities			35,399				25,361				352,175				159,216
Investment in short-term bank deposits			(2,867	)			(20,007	)			(5,054	)			(66,357	)
Proceeds from short-term bank deposits			–				–				107,843				8,213
Acquisition of business, net of cash acquired			(20,147	)			(383	)			(20,147	)			(39,738	)
Gain from sale of subsidiary			750				–				750				–
Acquisition of intangible asset			–				(1,106	)			–				(1,106	)
Purchase of property and equipment			(98	)			(326	)			(647	)			(1,303	)
Capitalization of internal-use software			–				(83	)			(661	)			(103	)
Other receivables and non-current assets			–				–				–				(300	)
Net cash provided by (used in) investing activities			13,037				(53,150	)			378,607				(28,818	)
Financing Activities
Repurchases of common stock			(10,009	)			–				(32,529	)			(100,081	)
Proceeds from exercise of share options			160				989				3,371				3,349
Payment of earn out			–				(4,357	)			(2,486	)			(4,357	)
Proceeds from withholding tax related to employees’ exercises of share options and RSUs			632				879				(153	)			859
Repayment of debt to previous shareholder of the acquired business			–				–				–				(3,992	)
Repayment of convertible notes at maturity			(460,000	)			–				(460,000	)			–
Net cash (used in) financing activities			(469,217	)			(2,489	)			(491,797	)			(104,222	)
Effect of exchange rate fluctuations on cash and cash equivalents			(136	)			(168	)			344				(230	)
Decrease in cash, cash equivalents			(434,446	)			(25,773	)			(8,257	)			(50,202	)
Cash, cash equivalents at the beginning of period			559,661				159,245				133,472				183,674
Cash and cash equivalents at the end of period		$	125,215			$	133,472			$	125,215			$	133,472

REVENUE BREAKDOWN
(in thousands1)
		Three Months Ended								Year Ended
		December 31,								December 31,
			2025				2024				2025				2024
Marketplace Revenue		$	71,534			$	73,510			$	297,489			$	303,069
Annual Active Buyers			3,135				3,630				3,135				3,630
Annual Spend per Buyer		$	342			$	302			$	342			$	302
Marketplace Take Rate			27.7	%			27.6	%			27.7	%			27.6	%
Services Revenue		$	35,640			$	30,156			$	133,420			$	88,412
Total Revenue		$	107,174			$	103,666			$	430,909			$	391,481
1. Except for Annual Spend per Buyer and Marketplace Take Rate.

RECONCILIATION OF GAAP TO NON-GAAP GROSS PROFIT
(in thousands, except gross margin data)
		Q4’24				Q1’25				Q2’25				Q3’25				Q4’25				FY 2024				FY 2025
										(Unaudited)												(Unaudited)				(Unaudited)
GAAP gross profit		$	83,465			$	86,788			$	88,264			$	88,137			$	88,304			$	320,915			$	351,493
Add:
Share-based compensation			445				423				403				365				39				2,136				1,230
Depreciation and amortization			3,198				3,164				3,155				2,186				2,446				7,017				10,951
Restructuring costs			–				–				–				238				(35	)			–				203
Earn-out revaluation, acquisition related costs and other			17				44				–				(43	)			6				28				7
Non-GAAP gross profit		$	87,125			$	90,419			$	91,822			$	90,883			$	90,760			$	330,096			$	363,884
Non-GAAP gross margin			84.0	%			84.4	%			84.5	%			84.2	%			84.7	%			84.3	%			84.4	%
RECONCILIATION OF GAAP NET INCOME TO NON-GAAP NET INCOME AND NET INCOME PER SHARE
(in thousands, except share and per share data)
		Q4’24				Q1’25				Q2’25				Q3’25				Q4’25				FY 2024				FY 2025
										(Unaudited)												(Unaudited)				(Unaudited)
GAAP net income attributable to ordinary shareholders		$	12,838			$	798			$	3,188			$	5,537			$	11,460			$	18,246			$	20,983
Add:
Depreciation and amortization			4,328				4,284				4,089				3,074				3,245				10,476				14,692
Share-based compensation			18,020				15,754				14,055				11,925				9,655				73,942				51,389
Impairment of intangible assets			–				–				–				2,400				–				–				2,400
Restructuring costs			–				–				–				3,567				(143	)			–				3,424
Earn-out revaluation, acquisition related costs and other			4,240				4,599				5,294				3,111				7,854				5,631				20,858
Convertible notes amortization of discount and issuance costs			640				641				642				643				214				2,555				2,140
Taxes on income related to non-GAAP adjustments			(16,249	)			(380	)			(351	)			(235	)			(268	)			(16,610	)			(1,234	)
Exchange rate (gain)/loss, net			1,108				(642	)			531				431				126				859				446
Non-GAAP net income		$	24,925			$	25,054			$	27,448			$	30,453			$	32,143			$	95,099			$	115,098
Weighted average number of ordinary shares – basic			35,658,287				36,019,143				36,585,998				36,415,189				36,107,120				36,984,757				36,281,883
Non-GAAP basic net income per share attributable to ordinary shareholders		$	0.70			$	0.70			$	0.75			$	0.84			$	0.89			$	2.57			$	3.17
Weighted average number of ordinary shares – diluted			38,947,644				39,446,707				39,653,165				39,391,560				37,387,076				39,994,015				38,969,647
Non-GAAP diluted net income per share attributable to ordinary shareholders		$	0.64			$	0.64			$	0.69			$	0.77			$	0.86			$	2.38			$	2.95
RECONCILIATION OF GAAP NET INCOME TO ADJUSTED EBITDA
(in thousands, except adjusted EBITDA margin data)
		Q4’24				Q1’25				Q2’25				Q3’25				Q4’25				FY 2024				FY 2025
										(Unaudited)												(Unaudited)				(Unaudited)
GAAP net income		$	12,838			$	798			$	3,188			$	5,537			$	11,460			$	18,246			$	20,983
Add:
Financial income and other			(5,662	)			(7,325	)			(6,554	)			(6,815	)			(3,899	)			(27,706	)			(24,593	)
Taxes on income (tax benefit)			(13,054	)			1,332				1,377				1,382				(1,658	)			(6,358	)			2,433
Depreciation and amortization			4,328				4,284				4,089				3,074				3,245				10,476				14,692
Share-based compensation			18,020				15,754				14,055				11,925				9,655				73,942				51,389
Impairment of intangible assets			–				–				–				2,400				–				–				2,400
Restructuring costs			–				–				–				3,567				(143	)			–				3,424
Earn-out revaluation, acquisition related costs and other			4,240				4,599				5,294				3,111				7,854				5,631				20,858
Adjusted EBITDA		$	20,710			$	19,442			$	21,449			$	24,181			$	26,514			$	74,231			$	91,586
Adjusted EBITDA margin			20.0	%			18.1	%			19.7	%			22.4	%			24.7	%			19.0	%			21.3	%
RECONCILIATION OF GAAP TO NON-GAAP OPERATING EXPENSES
(In thousands)
		Q4’24				Q1’25				Q2’25				Q3’25				Q4’25				FY 2024				FY 2025
										(Unaudited)												(Unaudited)				(Unaudited)
GAAP research and development		$	22,329			$	23,627			$	23,994			$	25,150			$	17,893			$	90,241			$	90,664
Less:
Share-based compensation			5,563				4,730				4,129				3,229				2,333				23,569				14,421
Depreciation and amortization			247				265				313				309				301				831				1,188
Restructuring costs			–				–				–				2,258				(85	)			–				2,173
Earn-out revaluation, acquisition related costs and other			(672	)			65				62				(83	)			137				28				181
Non-GAAP research and development		$	17,191			$	18,567			$	19,490			$	19,437			$	15,207			$	65,813			$	72,701
GAAP sales and marketing		$	45,232			$	47,390			$	44,844			$	40,669			$	43,772			$	171,678			$	176,675
Less:
Share-based compensation			3,162				2,246				1,369				1,338				1,079				13,592				6,032
Depreciation and amortization			770				716				550				507				429				2,308				2,202
Impairment of intangible assets			–				–				–				–				2,400				–				2,400
Restructuring costs			–				–				–				829				(2	)			–				827
Earn-out revaluation, acquisition related costs and other			1,811				1,197				1,147				805				1,263				1,878				4,412
Non-GAAP sales and marketing		$	39,489			$	43,231			$	41,778			$	37,190			$	38,603			$	153,900			$	160,802
GAAP general and administrative		$	21,782			$	20,966			$	21,415			$	22,214			$	20,736			$	74,814			$	85,331
Less:
Share-based compensation			8,850				8,355				8,154				6,993				6,204				34,645				29,706
Depreciation and amortization			113				139				71				72				69				320				351
Impairment of intangible assets			–				–				–				2,400				(2,400	)			–				–
Restructuring costs			–				–				–				242				(21	)			–				221
Earn-out revaluation, acquisition related costs and other			3,084				3,293				4,085				2,432				6,448				3,697				16,258
Non-GAAP general and administrative		$	9,735			$	9,179			$	9,105			$	10,075			$	10,436			$	36,152			$	38,795
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW
(In thousands)
		Q4’24				Q1’25				Q2’25				Q3’25				Q4’25				FY 2024				FY 2025
										(Unaudited)												(Unaudited)				(Unaudited)
Net cash provided by operating activities		$	30,034			$	28,309			$	25,204			$	29,206			$	21,870			$	83,068			$	104,589
Purchase of property and equipment			(326	)			(287	)			(185	)			(77	)			(98	)			(1,303	)			(647	)
Capitalization of internal-use software			(83	)			(661	)			–				–				–				(103	)			(661	)
Free cash flow		$	29,625			$	27,361			$	25,019			$	29,129			$	21,772			$	81,662			$	103,281

Key Performance Metrics and Non-GAAP Financial Measures

This release includes certain key performance metrics and financial measures not based on GAAP, including Adjusted EBITDA, Adjusted EBITDA margin, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP net income (loss), non-GAAP net income (loss) per share, and free cash flow, as well as operating metrics, including marketplace Gross Merchandise Value or GMV, annual active buyers, annual spend per buyer and marketplace take rate. Some amounts in this release may not total due to rounding. All percentages have been calculated using unrounded amounts.

We define each of our non-GAAP measures of financial performance, as the respective GAAP balances shown in the above tables, adjusted for, as applicable, depreciation and amortization, share-based compensation expenses, contingent consideration revaluation, acquisition related costs and other, income taxes, amortization of discount and issuance costs of convertible note, financial (income) expenses, net and other. Amortization of acquired intangible assets is excluded from the measures, however, the revenue from the acquired companies is included, and their assets actively contribute to revenue generation. Non-GAAP gross profit margin represents non-GAAP gross profit expressed as a percentage of revenue. We define non-GAAP net income (loss) per share as non-GAAP net income (loss) divided by GAAP weighted-average number of ordinary shares basic and diluted. We use free cash flow as a liquidity measure and define it as a net cash provided by operating activities less capital expenditures.

We define GMV or marketplace Gross Merchandise Value as the total value of transactions ordered through our marketplace, excluding value-added tax, goods and services tax, service chargebacks and refunds. Annual active buyers on any given date is defined as buyers who have ordered a Gig on our marketplace within the last 12-month period, irrespective of cancellations. Annual spend per buyer on any given date is calculated by dividing our GMV within the last 12-month period by the number of annual active buyers as of such date. Marketplace take rate for a given period means marketplace revenue for such period divided by GMV for such period. When we refer in this release to the marketplace we refer to transactions conducted between buyers and freelancers on Fiverr.com. When we refer to the platform we refer to the marketplace and our additional services. We define Rule-of-30 as percentage of revenue growth plus Adjusted EBITDA Margin.

Management and our board of directors use certain metrics as supplemental measures of our performance that are not required by, or presented in accordance with GAAP because they assist us in comparing our operating performance on a consistent basis, as they remove the impact of items not directly resulting from our core operations. We also use these metrics for planning purposes, including the preparation of our internal annual operating budget and financial projections, to evaluate the performance and effectiveness of our strategic initiatives and capital expenditures and to evaluate our capacity to expand our business. In addition, we believe that free cash flow, which we use as a liquidity measure, is useful in evaluating our business because free cash flow reflects the cash surplus available or used to fund the expansion of our business after the payment of capital expenditures relating to the necessary components of ongoing operations. Capital expenditures consist primarily of property and equipment purchases and capitalized software costs.

Free cash flow should not be used as an alternative to, or superior to, cash from operating activities. In addition, Adjusted EBITDA, Adjusted EBITDA margin, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP net income (loss) and non-GAAP net income (loss) per share as well as operating metrics, including GMV, annual active buyers, annual spend per buyer and marketplace take rate should not be considered in isolation, as an alternative to, or superior to net income (loss), revenue, cash flows or other performance measure derived in accordance with GAAP. These metrics are frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Management believes that the presentation of non-GAAP metrics is an appropriate measure of operating performance because they eliminate the impact of expenses that do not relate directly to the performance of our underlying business.

These non-GAAP metrics should not be construed as an inference that our future results will be unaffected by unusual or other items. Additionally, Adjusted EBITDA and other non-GAAP metrics used herein are not intended to be a measure of free cash flow for management’s discretionary use, as they do not reflect our tax payments and certain other cash costs that may recur in the future, including, among other things, cash requirements for costs to replace assets being depreciated and amortized. Management compensates for these limitations by relying on our GAAP results in addition to using Adjusted EBITDA and other non-GAAP metrics as supplemental measures of our performance. Our measures of Adjusted EBITDA, free cash flow and other non-GAAP metrics used herein are not necessarily comparable to similarly titled captions of other companies due to different methods of calculation.

See the tables above regarding reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures.

We are not able to provide a reconciliation of Adjusted EBITDA guidance to net income (loss), the nearest comparable GAAP measure, and Adjusted EBITDA margin guidance for the first quarter of 2026, the fiscal year ending December 31, 2026, or the period ending December 31, 2027, because certain items that are excluded from Adjusted EBITDA and Adjusted EBITDA margin cannot be reasonably predicted or are not in our control. In particular, in the case of Adjusted EBITDA and Adjusted EBITDA margin, we are unable to forecast the timing or magnitude of share based compensation, amortization of intangible assets, impairment of intangible assets, income or loss on revaluation of contingent consideration, other acquisition-related costs, convertible notes amortization of discount and issuance costs and exchange rate income or loss, as applicable without unreasonable efforts, and these items could significantly impact, either individually or in the aggregate, GAAP measures in the future.

Forward Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding our expected financial performance and operational performance including, our business plans and strategy, our multi-year plan and expected business transitions, the long term growth of our business, AI services and developments, future investments and investment strategy, as well as statements that include the words “expect,” “intend,” “plan,” “believe,” “project,” “forecast,” “estimate,” “may,” “should,” “anticipate” and similar statements of a future or forward-looking nature. These forward-looking statements are based on management’s current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: our recent reduction in force could adversely affect our business, results of operations and financial condition; AI developments may present challenges for our industry and reduce the demand for some of our service offerings; our ability to successfully implement our business plan within adverse economic conditions that may impact consumers, business spending and the demand for our services or have a material adverse impact on our business, financial condition and results of operations; our ability to attract and retain a large community of buyers and freelancers; our ability to generate sufficient revenue to maintain profitability or positive net cash flow generated by operating activities; our ability to maintain and enhance our brand; our dependence on the continued growth and expansion of the market for freelancers and the services they offer; our dependence on traffic to our websites; our ability to maintain user engagement on our websites and to maintain and improve the quality of our platform; our operations within a competitive market; political, economic and military instability in Israel, including related to the war in Israel; our ability and the ability of third parties to protect our users’ personal or other data from a security breach and to comply with laws and regulations relating to data privacy, data protection and cybersecurity; our ability to manage our current and potential future growth; our dependence on decisions and developments in the mobile device industry, over which we do not have control; our ability to detect errors, defects or disruptions in our platform; our ability to comply with the terms of underlying licenses of open source software components on our platform; our ability to expand into markets outside the United States and our ability to manage the business and economic risks of international expansion and operations; our ability to achieve desired operating margins; our ability to comply with a wide variety of U.S. and international laws and regulations, including with regulatory frameworks around the development and use of AI; our ability to attract, recruit, retain and develop qualified employees; our reliance on Amazon Web Services; our ability to mitigate payment and fraud risks; our dependence on relationships with payment partners, banks and disbursement partners; and the other important factors discussed under the caption “Risk Factors” in our annual report on Form 20-F filed with the U.S. Securities and Exchange Commission (“SEC”) on February 19, 2025, as such factors may be updated from time to time in our other filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. In addition, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements that we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this release are inherently uncertain and may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Accordingly, you should not rely upon forward-looking statements as predictions of future events. In addition, the forward-looking statements made in this release relate only to events or information as of the date on which the statements are made in this release. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

________________________________
_{¹ See “Key Performance Metrics and Non-GAAP Financial Measures” and reconciliation tables at the end of this release for additional information regarding the non-GAAP metrics and Key Performance Metrics used in this release.}

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) — Getty Realty Corp. (NYSE: GTY) (the “Company”), a net lease REIT focused on convenience and automotive retail real estate, today announced the pricing of an underwritten public offering of an aggregate of 4,000,000 shares of its common stock sold on a forward basis in connection with the forward sale agreements described below, for gross proceeds of approximately $131 million. The forward purchasers (or their affiliates) and the Company have also granted the underwriters of the offering a 30-day option to purchase up to an additional 600,000 shares of common stock. The offering is expected to close on February 19, 2026, subject to customary closing conditions.

J.P. Morgan and Wells Fargo Securities acted as book-running managers for the offering.

In connection with the offering of shares of its common stock, the Company expects to enter into separate forward sale agreements with each of J.P. Morgan Securities LLC and Wells Fargo Securities (or their respective affiliates), each referred to in this capacity as the forward purchaser. In connection with such forward sale agreements, the forward purchasers (or their affiliates) are expected to borrow from third parties and sell to the underwriters an aggregate of 4,000,000 shares of the Company’s common stock (or 4,600,000 shares if the underwriters’ option is exercised in full and the Company elects to execute additional forward sale agreements). Pursuant to the terms of each forward sale agreement, and subject to its right to elect cash or net share settlement, the Company is obligated to issue and deliver, upon physical settlement of such forward sale agreement on one or more dates specified by the Company, the number of shares of the Company’s common stock underlying such forward sale agreement in exchange for a cash payment per share equal to the forward sale price under such forward sale agreement. The Company expects to physically settle the forward sale agreements and receive proceeds, subject to certain adjustments, from the sale of its shares of common stock upon one or more such physical settlements within approximately one year from the date of the prospectus supplement relating to the offering.

The Company will not initially receive any proceeds from the sale of shares of its common stock by the forward purchasers (or their affiliates). The Company intends to use the net proceeds from the offering and the net proceeds, if any, received upon the settlement of the forward sale agreements to fund property acquisitions, to repay indebtedness outstanding under its revolving credit facility, for working capital and other general corporate purposes, or a combination of the foregoing.

An automatic shelf registration statement on Form S-3 relating to the public offering of the shares of common stock described above was filed with the Securities and Exchange Commission (the “SEC”) and became effective on January 5, 2024. A preliminary prospectus supplement relating to the offering has been filed with the SEC. When available, copies of the prospectus supplement and related base prospectus for the offering may be obtained on the website of the SEC, www.sec.gov, or by contacting J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email at [email protected] and [email protected]; or Wells Fargo Securities, 90 South 7th Street, 5th Floor, Minneapolis, MN 55402, at 800-645-3751 (option #5) or email a request to [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any shares of common stock, nor shall there be any sale of such common stock in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

The offering of these securities may be made only by means of a prospectus and related prospectus supplement meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Forward-Looking Statements

CERTAIN STATEMENTS CONTAINED HEREIN MAY CONSTITUTE “FORWARD-LOOKING STATEMENTS” WITHIN THE MEANING OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. WHEN THE WORDS “BELIEVES,” “EXPECTS,” “PLANS,” “PROJECTS,” “ESTIMATES,” “ANTICIPATES,” “PREDICTS,” “OUTLOOK” AND SIMILAR EXPRESSIONS ARE USED, THEY IDENTIFY FORWARD-LOOKING STATEMENTS. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON MANAGEMENT’S CURRENT BELIEFS AND ASSUMPTIONS AND INFORMATION CURRENTLY AVAILABLE TO MANAGEMENT AND INVOLVE KNOWN AND UNKNOWN RISKS, UNCERTAINTIES AND OTHER FACTORS WHICH MAY CAUSE THE ACTUAL RESULTS, PERFORMANCE OR ACHIEVEMENTS OF THE COMPANY TO BE MATERIALLY DIFFERENT FROM ANY FUTURE RESULTS, PERFORMANCE OR ACHIEVEMENTS EXPRESSED OR IMPLIED BY THESE FORWARD-LOOKING STATEMENTS. EXAMPLES OF FORWARD-LOOKING STATEMENTS INCLUDE BUT ARE NOT LIMITED TO STATEMENTS REGARDING THE EXPECTED SETTLEMENT OF THE FORWARD SALE AGREEMENTS AND THE USE OF PROCEEDS FROM THE OFFERING AND ANY PROCEEDS RECEIVED FROM THE SETTLEMENT OF THE FORWARD SALE AGREEMENTS.

INFORMATION CONCERNING FACTORS THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THESE FORWARD-LOOKING STATEMENTS CAN BE FOUND ELSEWHERE IN THIS PRESS RELEASE, INCLUDING, WITHOUT LIMITATION, THOSE STATEMENTS IN THE COMPANY’S PERIODIC REPORTS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. THE COMPANY UNDERTAKES NO OBLIGATION TO PUBLICLY RELEASE REVISIONS TO THESE FORWARD-LOOKING STATEMENTS TO REFLECT FUTURE EVENTS OR CIRCUMSTANCES OR REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.

About Getty Realty Corp.

Getty Realty Corp. is a publicly traded, net lease REIT specializing in the acquisition, financing and development of convenience, automotive and other single tenant retail real estate. As of December 31, 2025, the Company’s portfolio included 1,174 freestanding properties located in 44 states across the United States and Washington, D.C.

Contact:		Investor Relations
		(646) 349-0598
		[email protected]

MIRAMAR, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend health span by targeting the link between chronic inflammation and disease, today announced the pricing of its follow-on offering of an aggregate of 2,477,292 units at a purchase price of $0.6055 per unit priced at-the-market under Nasdaq rules. Each unit consists of one share of common stock (or pre-funded warrant in lieu thereof) and one warrant, each to purchase one share of common stock. The warrant will have an exercise price of $0.6055 per share, will be exercisable upon shareholder approval, and will expire on the five-year anniversary from such date of shareholder approval. The shares of common stock (or pre-funded warrants) and the warrant comprising the units are immediately separable and will be issued separately in this offering. The closing of the offering is expected to occur on or about February 19, 2026, subject to the satisfaction of customary closing conditions.

Maxim Group LLC is acting as the sole placement agent for the offering.

The gross proceeds from the offering, before deducting the placement agent’s fees and other offering expenses, are expected to be approximately $1.5 million. The Company intends to use the net proceeds from this offering for funding preclinical and clinical development, including the clinical trials for HCW9302, and general corporate purposes.

In addition, the Company has entered into a privately negotiated agreement with the holder of certain existing outstanding warrants to purchase up to 3,020,410 shares of common stock (the “Existing Warrants”) to reduce the exercise price of such Existing Warrants from $2.41 per share to $0.6055 per share. The reduction of the exercise price of the Existing Warrants is subject to shareholder approval.

The securities described above are being offered pursuant to a registration statement on Form S-1, as amended (File No. 333-293396), which was declared effective by the Securities and Exchange Commission (the “SEC”) on February 17, 2026. The offering is being made only by means of a prospectus which forms a part of the effective registration statement. A preliminary prospectus relating to the offering has been filed with the SEC. Electronic copies of the final prospectus, when available, may be obtained on the SEC’s website at www.sec.gov and may also be obtained by contacting Maxim Group LLC at 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Prospectus Department, or by telephone at (212) 895-3745 or by email at [email protected].

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About HCW Biologics:

HCW Biologics Inc. (NASDAQ: HCWB) is a clinical-stage biopharmaceutical company developing proprietary immunotherapies to treat diseases promoted by chronic inflammation, especially age-related and senescence-associated diseases. The Company’s immunotherapeutics represent a new class of drugs that it believes have the potential to fundamentally change the treatment of cancer and many other diseases and conditions that are promoted by chronic inflammation — and in doing so, improve patients’ quality of life and potentially extend longevity. Chronic inflammation, including inflammaging, is believed to be a significant contributing factor to senescence-associated diseases and conditions that diminish health span, including many types of cancer, autoimmune diseases, and neurodegenerative diseases, as well as many indications that impact quality-of-life that are not life-threatening. The Company’s lead product candidate, HCW9302, was developed using the Company’s legacy TOBI™ (Tissue factOr-Based fusIon) platform. The Company has created another drug discovery technology, the TRBC platform, which is not based on Tissue Factor. The TRBC platform has the capability to construct immunotherapeutics that not only activate and target immune responses but are also equipped with receptors that specifically target cancerous or infected cells. This platform is a versatile scaffold that enables the creation of multiple classes of immunotherapeutic compounds: Class I: Multi-Functional Immune Cell Stimulators; Class II: Second-Generation Immune Checkpoint Inhibitors; Class III: Multi-Specific Targeting Fusions and Enhanced Immune Cell Engagers. These novel immunotherapeutics are being developed for treatment of a wide range of disease indications, including oncology, autoimmune diseases, and improving quality of life conditions. The Company has constructed over 50 molecules using the TRBC platform. HCW9302 is the lead product candidate for the Company’s clinical development program for autoimmune diseases and other proinflammatory conditions. The Company has dosed the first patient in a Company-sponsored, multi-center Phase 1 clinical trial to evaluate HCW9302 in an autoimmune disease (NCT07049328). The IND-enabling process is underway for three TRBC-based molecules which were selected as the lead product candidates for other clinical development programs in cancer and age-related diseases based on promising preclinical data. The Company has two licensing programs in which it has licensed exclusive rights for some of its proprietary molecules.

Forward-Looking Statements

Statements in this press release contain “forward-looking statements” that are subject to substantial risks and uncertainties. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “expect,” “believe,” “will,” “may,” “should,” “estimate,” “project,” “outlook,” “forecast” or other similar words and include, the statements on the closing of the offering and the satisfaction of closing conditions and use of proceeds in the offering, the Company’s ability to develop new immunotherapeutic treatments for non-oncology or oncology indications; the capabilities of the Company’s new platform and the effectiveness of new fusion proteins developed using the new platform. Forward-looking statements are based on the Company’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Factors that could cause actual results to differ include, but are not limited to, the risks and uncertainties that are described in the section titled “Risk Factors” in the annual report on Form 10-K filed with the United States Securities and Exchange Commission (the “SEC”) on March 28, 2025 and in other filings filed from time to time with the SEC. Forward-looking statements contained in this press release are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

Company Contact:

Rebecca Byam
CFO
HCW Biologics Inc.
[email protected]

ADDISON, Texas, Feb. 17, 2026 (GLOBE NEWSWIRE) — CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announced that it will report its fourth quarter 2025 financial results on February 24, 2026, premarket. The Company will also host its earnings call starting at 8:30 a.m. Eastern Time (7:30 a.m. CT). The Company’s financial results and presentation will be posted on its website at www.cecoenviro.com.

The details for the webcast are:

When: Tuesday, February 24 at 8:30 a.m. Eastern Time

Where: https://edge.media-server.com/mmc/p/esi9fzv8

How: Live over the internet – Simply log on to the web at the address above

Register to receive the dial-in info and a unique pin: https://register-conf.media-server.com/register/BIef187ad40fff4b6eaf15a109421408ae

A replay of the conference call will be available on the Company’s website shortly after the live webcast has concluded.

ABOUT CECO ENVIRONMENTAL

CECO Environmental is a leading environmentally focused, diversified industrial company, serving a broad landscape of industrial air, industrial water, and energy transition markets globally through its key business segments: Engineered Systems and Industrial Process Solutions. Providing innovative technology and application expertise, CECO helps companies grow their business with safe, clean, and more efficient solutions that help protect people, the environment and industrial equipment. In regions around the world, CECO works to improve air quality, optimize the energy value chain, and provide custom solutions for applications in power generation, petrochemical processing, refining, midstream gas transport and treatment, electric vehicle and battery production, metals and mineral processing, polysilicon production, battery recycling, beverage can production, and produced and oily water/wastewater treatment along with a wide range of other industrial applications. CECO is listed on Nasdaq under the ticker symbol “CECO.” Incorporated in 1966, CECO’s global headquarters is in Addison, Texas. For more information, please visit www.cecoenviro.com.

CECO Environmental Investor Contact:

Marcio Pinto
Vice President – Financial Planning & Investor Relations
888-990-6670
[email protected]
        
Steven Hooser and Jean Marie Young
Three Part Advisors
214-872-2710
[email protected]

CECO Environmental Media and Communication Contact:

Rachael Gallodoro
214-350-2992
[email protected]

SAN DIEGO, Feb. 17, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that the PayPal class action lawsuit seeks to represent purchasers or acquirers of PayPal Holdings, Inc. (NASDAQ: PYPL) common stock between February 25, 2025 and February 2, 2026, inclusive (the “Class Period”). Captioned Goodman v. PayPal Holdings, Inc., No. 26-cv-01381 (N.D. Cal.), the PayPal class action lawsuit charges PayPal and certain of PayPal’s top current and former executives with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the

PayPal

class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-paypal-holdings-class-action-lawsuit-pypl.html

You can also contact attorney

J.C. Sanchez

of Robbins Geller by calling 800/449-4900 or via e-mail at

[email protected]

.

CASE ALLEGATIONS: PayPal operates a technology platform that enables digital payments for merchants and consumers.

The PayPal class action lawsuit alleges that defendants throughout the Class Period created the false impression that they possessed reliable information pertaining to PayPal’s projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations. In truth, PayPal’s optimistic plan for growth through various initiatives to bolster PayPal’s Branded Checkout offerings fell short of reality as the 2027 targets were not achievable under the tenure of defendant James Alexander Chriss as CEO; they required both an unrealistically stable consumer landscape and strong execution with clear direction from PayPal and its management, the complaint alleges.

The PayPal class action lawsuit further alleges that on February 3, 2026, PayPal announced its financial results for the fourth quarter and full fiscal year 2025, disclosing disappointing earnings results with worsening performance in Branded Checkout and the withdrawal of its 2027 financial targets provided one year before. PayPal allegedly attributed its results and lowered guidance to a combination of macroeconomic factors, competition, and “‘operational and deployment issues’ across all regions.” The complaint alleges that PayPal also revealed the transition of its CEO, defendant James Alexander Chriss. On this news, the price of PayPal common stock fell more than 20%, according to the complaint.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired PayPal common stock during the Class Period to seek appointment as lead plaintiff in the PayPal class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the PayPal investor class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the PayPal shareholder class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the PayPal class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes.

Services may be performed by attorneys in any of our offices. 

Contact:
        Robbins Geller Rudman & Dowd LLP
        J.C. Sanchez
        655 W. Broadway, Suite 1900, San Diego, CA 92101
        800-449-4900
        [email protected]